Company on brink takes psilocybin to trial for fragile X syndrome

The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.

Episode metadata supplied by the publisher feed · Published May 5, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Company on brink takes psilocybin to trial for fragile X syndrome

0:00 9:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 9 minutes long.

This episode was published on May 5, 2023.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!